Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

Rasulov Alisher Sobirovich

Работ: 6

Candidate of medical sciences, docent, Samarkand state medical institute, Department of Pediatrics of the Faculty of Postgraduate Education, Samarkand city, Uzbekistan,

  1. Prevention of rickets depending on the level of 25 (oh) d in the serum of koi in children 1 year of age in uzbekistan

    Rasulova Nadira Alisherovna, Rasulov Alisher Sobirovich, Sharipov Rustam Xaitovich +2

    СтатьяHuman Health and DiseaseCENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES2021Цитирований: 0
    ABI

  2. Differentiated approach to treatment convenience in early children

    Sharipov Rustam Xaitovich, Rasulova Nadira Alisherovna, Rasulov Alisher Sobirovich +2

    СтатьяChild and Adolescent HealthACADEMICIA An International Multidisciplinary Research Journal2021Цитирований: 0
    ABI

  3. VITAMIN D AND ITS EFFECT ON THE DEVELOPMENT OF RICKITIS IN CHILDREN

    Rasulova Nadira Alisherovna, Rasulov Alisher Sobirovich

    СтатьяHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)2022Цитирований: 0
    ABI

  4. FEATURES OF PREVENTION AND TREATMENT OF SEVERAL CONDITIONS IN CHILDREN OF EARLY AGE

    Rasulova Nоdira Alisherovna, Rasulov Alisher Sobirovich, Irbutayeva Lola Tashbekovna

    СтатьяHermeneutics and Narrative IdentityZenodo (CERN European Organization for Nuclear Research)2022Цитирований: 0
    ABI

  5. ASSESSMENT OF THE FACTORS OF RICKETS DEVELOPMENT AND THE CONSEQUENCES OF PERINATAL DAMAGE TO THE NERVOUS SYSTEM IN YOUNG CHILDREN

    Sharipov Rustam Khaitovich, Rasulova Nоdira Alisherovna, Rasulov Alisher Sobirovich

    СтатьяHuman Health and DiseaseZenodo (CERN European Organization for Nuclear Research)2023Цитирований: 0
    ABI

  6. MODIFIED APPROACH TO THE TREATMENT OF RICKETS IN THE CONDITIONS OF UZBEKISTAN

    Rasulova Nоdira Alisherovna, Rasulov Alisher Sobirovich

    СтатьяEducation, Innovation and Language StudiesZenodo (CERN European Organization for Nuclear Research)2023Цитирований: 0
    ABI